✕

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Is UnitedHealth (UNH) a Good or Bad Investment at Today’s Price?

The insurance float produces $27.02bn of operating cash against $14.12bn of profit, but revenue grew 0.40% and a 3.14% margin means claims costs decide the year.

UnitedHealth Group Incorporated (NYSE:UNH) closed at $371.90 on October 2, up 3.66% over twelve months.

The shares traded as low as $255.97 and as high as $461.62 within those twelve months. That is a range of more than two hundred dollars on a company whose revenue barely moved. The margin explains why the price is so unstable.

READ ALSO: Here is Why Tripadvisor (TRIP) is a Bad Investment at Today’s Price

A 3.14% Margin Makes Everything Volatile:

UnitedHealth collected $450.53 billion of revenue and kept $14.12 billion of it. That is a net margin of 3.14%. On a number that large, three percent is real money, but it means the gap between a good year and a bad one is very narrow.

Medical costs are the reason. An insurer collects premiums set in advance and pays claims it cannot predict, so a small move in how much care people use moves the profit sharply. Last quarter it moved the right way. Earnings grew 61.00% while revenue grew 0.40%.

That is not a company selling more. It is a company whose claims came in better than the premiums assumed, and that can reverse. Cash is the genuinely strong part. Operating cash flow was $27.02 billion and free cash flow $24.27 billion, both well above the $14.12 billion of reported profit.

An insurer holds premiums before paying claims, which is why the cash runs ahead.

DON’T MISS: What is eBay’s (EBAY) Economic Moat, and is it Widening or Narrowing?

The Revenue Has Stopped Growing:

The number that should worry an owner is 0.40%. UnitedHealth is the largest health insurer in the United States, and its revenue is effectively flat. A business of this size grows by adding members or by raising premiums, and neither is currently moving the total.

Return on equity is 14.15%, which is respectable for a business running a three percent margin. The debt is manageable rather than small, at $73.33 billion against $31.47 billion of cash.

The current ratio of 0.78 looks alarming and mostly is not, because an insurer’s liabilities include claims reserves rather than bills due next month.

What the figures cannot settle is regulation. A company earning 3.14% on $450.53 billion of healthcare spending is exposed to decisions about what it may charge, and no balance sheet protects against that. Growth of 0.40% is the number that makes this a value question rather than a growth one.

UNH recently ranked second in our list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. To see which stock outranked it, click HERE.

The Valuation Case:

UnitedHealth closed at $371.90 on October 2 and is worth $334.76 billion. Sustainability rests on claims costs, which the company influences and does not control. The float and the scale are durable, and the margin converting them is thin enough to vanish in a bad year.

On price, the stock is cheap on sales and ordinary on earnings. Price-to-sales is 0.75, while the trailing multiple is 23.97 times and the forward multiple is 16.58 times. A PEG ratio of 1.01 means the market is paying roughly the growth rate and no more.

The dividend yields 2.50% on a payout ratio of 57.56%, so more than half the earnings leave the company. This year’s best-performing dividend stocks are ranked here.

Conclusion:

The cash is the strongest part of this company. Operating cash flow of $27.02 billion against $14.12 billion of reported profit is the insurance float working, and 16.58 times forward earnings is not a demanding price for the largest operator in the industry. However, revenue grew 0.40%, and a 3.14% net margin means a small change in claims costs moves the profit a long way. Last quarter’s 61.00% earnings growth came from costs rather than sales. The number to watch is the medical cost ratio, because at this margin nothing else decides the year.

Market Sentiment:

UnitedHealth Group Incorporated was held by 143 hedge funds with a combined stake value of about $16.05 billion at the end of Q2 2026 in the Insider Monkey database. This is up from 130 hedge fund holders with a cumulative investment value of around $9.91 billion in the previous quarter.

READ NEXT: Here is Why Tripadvisor (TRIP) is a Bad Investment at Today’s Price and What is eBay’s (EBAY) Economic Moat, and is it Widening or Narrowing?

This article is originally published at Insider Monkey.